New drug cocktail tested for Tough-to-Treat blood cancer
NCT ID NCT01665794
Summary
This study tested a combination of three drugs—pomalidomide, dexamethasone, and carfilzomib—for people with multiple myeloma that had returned or stopped responding to prior treatments. The main goals were to find a safe dose and see how well the combination worked to control the cancer. Treatment continued as long as it was helping and side effects were manageable.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
University Health Network - Princess Margaret Cancer Center
Toronto, Ontario, MISG 2M9, Canada
-
University of Chicago Comprehensive Cancer Center
Chicago, Illinois, 60637-1470, United States
-
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, 48109, United States
-
Wayne State University - Karmonos Cancer Center
Detroit, Michigan, 48201, United States
Conditions
Explore the condition pages connected to this study.